The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Severe Alterations in Lipid Composition of Frontal Cortex Lipid Rafts from Parkinson’s Disease and Incidental Parkinson’s Disease
Open accessAbstract
Lipid rafts are cholesterol- and sphingomyelin-enriched microdomains that provide a highly saturated and viscous physicochemical microenvironment to promote protein-lipid and protein-protein interactions. We purified lipid rafts from human frontal cortex from normal, early motor stages of Parkinson's disease (PD) and incidental Parkinson's disease (iPD) subjects and analyzed their lipid composition. We observed that lipid rafts from PD and iPD cortices exhibit dramatic reductions in their contents of n-3 and n-6 long-chain polyunsaturated fatty acids, especially docosahexaenoic acid (22:6-n3) and arachidonic acid (20:4n-6). Also, saturated fatty acids (16:0 and 18:0) were significantly higher than in control brains. Paralleling these findings, unsaturation and peroxidability indices were considerably reduced in PD and iPD lipid rafts. Lipid classes were also affected in PD and iPD lipid rafts. Thus, phosphatidylserine and phosphatidylinositol were increased in PD and iPD, whereas cerebrosides and sulfatides and plasmalogen levels were considerably diminished. Our data pinpoint a dramatic increase in lipid raft order due to the aberrant biochemical structure in PD and iPD and indicate that these abnormalities of lipid rafts in the frontal cortex occur at early stages of PD pathology. The findings correlate with abnormal lipid raft signaling and cognitive decline observed during the development of these neurodegenerative disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts
Brown, D. A., & London, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000005200 · Cited by 2,344
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes
Davidson, W. S., Jonas, A., Clayton, D. F., & George, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9443 · Cited by 1,585
Neuropathology of Parkinsonʼs Disease
Forno, L. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199603000-00001 · Cited by 1,465
Basal Lipid Peroxidation in Substantia Nigra Is Increased in Parkinson's Disease
Dexter, D. T., Carter, C. J., Wells, F. R., Javoy‐Agid, F., Agid, Y., Lees, A., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb09133.x · Cited by 1,397
Lipid rafts: bringing order to chaos
Pike, L. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200021-jlr200 · Cited by 1,138
STRUCTURE, FUNCTION, AND DIETARY REGULATION OF Δ6, Δ5, AND Δ9 DESATURASES
Nakamura, M. T., & Nara, T. Y. (2004) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.24.121803.063211 · Cited by 1,073
Applied Discriminant Analysis.
Hand, D. J., & Huberty, C. J. (1995) · Biometrics · doi:10.2307/2533021 · Cited by 986
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981
Docosahexaenoic acid: Membrane properties of a unique fatty acid
Stillwell, W., & Wassall, S. R. (2003) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(03)00101-4 · Cited by 872
Lipid raft microdomains and neurotransmitter signalling
Allen, J. A., Halverson-Tamboli, R. A., & Rasenick, M. M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2059 · Cited by 852
Ceramide in the eukaryotic stress response
Hannun, Y. A., & Luberto, C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01694-3 · Cited by 727
Braak, H., Del Tredici, K., Bratzke, H., Hamm-Clement, J., Sandmann-Keil, D., & Rüb, U. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1301-4 · Cited by 708
Heckler, C. E. (1995) · Technometrics · doi:10.1080/00401706.1995.10484350 · Cited by 569
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00128-6 · Cited by 555
The kinetics of the autoxidation of polyunsaturated fatty acids
Cosgrove, J. P., Church, D. F., & Pryor, W. A. (1987) · Lipids · doi:10.1007/bf02533996 · Cited by 525
Lipid Rafts Mediate the Synaptic Localization of α-Synuclein
Fortin, D. L., Troyer, M. D., Nakamura, K., Kubo, S.-I., Anthony, M. D., & Edwards, R. H. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1594-04.2004 · Cited by 518
Pike, L. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800040-jlr200 · Cited by 493
Functions and biosynthesis of plasmalogens in health and disease
Brites, P., Waterham, H. R., & Wanders, R. J. A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2003.12.010 · Cited by 416
(1964) · The Lancet · doi:10.1016/s0140-6736(64)90527-6 · Cited by 370
Farooqui, A. A., Ong, W.-Y., & Horrocks, L. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.7 · Cited by 368
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease
Dickson, D. W., Fujishiro, H., DelleDonne, A., Menke, J., Ahmed, Z., Klos, K. J., Josephs, K. A., Frigerio, R., Burnett, M., Parisi, J. E., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0345-7 · Cited by 364
Dexter, D. T., Sian, J., Rose, S., Hindmarsh, J. G., Mann, V. M., Cooper, J. M., Wells, F. R., Daniel, S. E., Lees, A. J., Schapira, A. H. V., et al. (1994) · Annals of Neurology · doi:10.1002/ana.410350107 · Cited by 317
α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia
Parkkinen, L., Kauppinen, T., Pirttilä, T., Autere, J. M., & Alafuzoff, I. (2005) · Annals of Neurology · doi:10.1002/ana.20321 · Cited by 315
Lipid Alterations in Lipid Rafts from Alzheimer's Disease Human Brain Cortex
Martín, V., Fabelo, N., Santpere, G., Puig, B., Marín, R., Ferrer, I., & Díaz, M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1242 · Cited by 271
Self-citationPAMPLONA, R., BARJA, G., & PORTERO‐OTÍN, M. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02118.x · Cited by 267
Evidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease
Dalfó, E., Portero-Otín, M., Ayala, V., Martínez, A., Pamplona, R., & Ferrer, I. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000179050.54522.5a · Cited by 261
Self-citationSwinnen, J. V., Van Veldhoven, P. P., Timmermans, L., De Schrijver, E., Brusselmans, K., Vanderhoydonc, F., Van de Sande, T., Heemers, H., Heyns, W., & Verhoeven, G. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00265-1 · Cited by 259
Lewy body-related ?-synucleinopathy in the aged human brain
Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 256
Dietary (n-3) Polyunsaturated Fatty Acids Remodel Mouse T-Cell Lipid Rafts
Fan, Y.-Y., McMurray, D. N., Ly, L. H., & Chapkin, R. S. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.6.1913 · Cited by 232
A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
Jellinger, K. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.07.006 · Cited by 232
A critical reappraisal of current staging of Lewy-related pathology in human brain
Jellinger, K. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0406-y · Cited by 230
LIPID PEROXIDATION AS CAUSE OF NIGRAL CELL DEATH IN PARKINSON'S DISEASE
Dexter, D., Carter, C., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92471-2 · Cited by 207
Metzler-Baddeley, C. (2007) · Cortex · doi:10.1016/s0010-9452(08)70489-1 · Cited by 202
Lewy Body-Related α-Synucleinopathy in Aging
Saito, Y., Ruberu, N. N., Sawabe, M., Arai, T., Kazama, H., Hosoi, T., Yamanouchi, H., & Murayama, S. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.742 · Cited by 200
A Combinatorial Code for the Interaction of α-Synuclein with Membranes
Kubo, S.-I., Nemani, V. M., Chalkley, R. J., Anthony, M. D., Hattori, N., Mizuno, Y., Edwards, R. H., & Fortin, D. L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504894200 · Cited by 197
n−3 PUFA and membrane microdomains: a new frontier in bioactive lipid research
Ma, D. W. L., Seo, J., Switzer, K. C., Fan, Y.-Y., McMurray, D. N., Lupton, J. R., & Chapkin, R. S. (2004) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2004.08.002 · Cited by 190
Sharon, R., Bar-Joseph, I., Mirick, G. E., Serhan, C. N., & Selkoe, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309127200 · Cited by 187
Ferrer, I. (2009) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-009-9243-5 · Cited by 172
Self-citationCortico-basal ganglia-cortical circuitry in Parkinson's disease reconsidered
Braak, H., & Tredici, K. D. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.001 · Cited by 158
Navarro, A., Boveris, A., Bández, M. J., Sánchez-del-Pino, M. J., Gómez, C., Muntané, G., & Ferrer, I. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.03.007 · Cited by 142
Self-citationDeacylation and Reacylation of Neural Membrane Glycerophospholipids: A Matter of Life and Death
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:14:3:123 · Cited by 133
Shaikh, S. R., Rockett, B. D., & Carraway, K. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.108720 · Cited by 132
Mice Deficient in Group IV Cytosolic Phospholipase A2 Are Resistant to MPTP Neurotoxicity
Klivènyi, P., Beal, M. F., Ferrante, R. J., et al. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062634.x · Cited by 129
Kidd, P. M. (2000) · PubMed · Cited by 128
Ford, D. A., & Gross, R. W. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3479 · Cited by 125
Ferrer, I. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.02.004 · Cited by 123
Self-citationShaikh, S. R., Cherezov, V., Caffrey, M., Stillwell, W. H., & Wassall, S. R. (2003) · Biochemistry · doi:10.1021/bi034931+ · Cited by 105
Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders
MNH (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.6.677 · Cited by 103
Lipid-dependent Recruitment of Neuronal Src to Lipid Rafts in the Brain
Mukherjee, A., Arnaud, L., & Cooper, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306440200 · Cited by 100
VDAC and ERα interaction in caveolae from human cortex is altered in Alzheimer's disease
Ramírez, C. M., González‐Gómez, M., Díaz, M. L., Alonso, R., Ferrer, I., Santpere, G., Puig, B., Meyer, G., & Marín, R. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.07.001 · Cited by 93
Self-citationRango, M., Bonifati, C., & Bresolin, N. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600192 · Cited by 91
Cheng, H., Xu, J., McKeel, D. W., & Han, X. (2003) · PubMed · Cited by 90
Marín, R., Ramírez, C. M., Marin, R., Ramírez, C. M., González‐Gómez, M., González-Muñoz, E., Antonio Zorzano, A., Camps, M., Alonso, R., & Díaz, M. L. (2007) · Molecular Membrane Biology · doi:10.1080/09687860601055559 · Cited by 86
Self-citationA Whole-Brain Analysis in De Novo Parkinson Disease
Tessa, C., Giannelli, M., Nave, R. D., Lucetti, C., Berti, C., Ginestroni, A., Bonuccelli, U., & Mascalchi, M. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0900 · Cited by 81
Aggregation of α-synuclein in the pathogenesis of Parkinson’s disease
Iwatsubo, T. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1303-x · Cited by 61
Ross, B. M., Mamalias, N., Moszczyńska, A., Rajput, A. H., & Kish, S. J. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00501-7 · Cited by 54
Gómez, A., & Ferrer, I. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21904 · Cited by 52
Self-citationWallin, A., Ekberg, S., LIND, K., Milos, V., Granérus, A., & Granérus, G. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00887.x · Cited by 24
Cited by
Functions of plasmalogen lipids in health and disease
Braverman, N. E., & Moser, A. B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.05.008 · Cited by 1,082
Dyall, S. C. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00052 · Cited by 943
Structural and functional roles of ether lipids
Dean, J. M., & Lodhi, I. J. (2018) · Protein & Cell · doi:10.1007/s13238-017-0423-5 · Cited by 672
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
Murphy, K. E., Gysbers, A. M., Abbott, S. K., Tayebi, N., Kim, W. S., Sidransky, E., Cooper, A., Garner, B., & Halliday, G. M. (2014) · Brain · doi:10.1093/brain/awt367 · Cited by 475
Gubert, C., Kong, G., Renoir, T., & Hannan, A. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104621 · Cited by 363
Metadata
- Authors
- Fabelo, N., Martín, V., Santpere, G., Marín, R., Torrent, L., Ferrer, I., & Díaz, M.
- Venue
- Molecular Medicine
- Published
- 2011-06-22
- Volume
- 17
- Issue
- 9-10
- Pages
- 1107-1118
- ISSN
- 1076-1551 (ISSN-L)
- 1528-3658
- OpenAlex
- W2179386188
- Cited by
- 379
- References
- 62
- FWCI
- 10.06
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.